Dow Flat Again as Trade Buzz Does Nothing for Stocks

A number of drug stocks are outperforming today

Dec 10, 2019 at 12:03 PM
facebook X logo linkedin

It's another day of weak price action for stocks on Wall Street, with traders mostly holding tight ahead of tomorrow's Fed decision. Ahead of the opening bell, it looked as though apparent headway in U.S.-China trade relations could lift stocks, but the risk-off sentiment has remained. The Dow Jones Industrial Average (DJI) and S&P 500 Index (SPX) are essentially flat at the halfway point, while the Nasdaq Composite (IXIC) outperforms slightly thanks to some big moves from drug stocks.

midday market stats dec 10

One name seeing unusual options trading is CVS Health Corp (NYSE:CVS), as the stock slumps 2.8% to $72.93, breaking support at the 20-day moving average. Put volume is running at twice the expected clip, and there are new positions opening at the December 73 put. Those buying the contract are expecting more downside in the coming weeks. CVS shares hit a new 52-week high of $77 just two weeks ago, and their 14-day Relative Strength Index (RSI) has been moving lower out of overbought conditions since that time.

One of the best stocks today is Magenta Therapeutics Inc (NASDAQ:MGTA), thanks to a gene therapy breakthrough. The shares have gained 16.6% to trade at $14.92, putting them on pace for their highest close since June. MGTA is now up 161% on a year-to-date basis.

Another healthcare stock on the rise is bluebird bio Inc (NASDAQ:BLUE), last seen 8% higher at $82.72. This comes after the drugmaker last evening presented data for its CAR-T cell therapy in patients with multiple myeloma, and Jefferies suggested that even higher doses of the treatment could result in better data down the road. BLUE shares are still fairly close to 52-week-low territory, though, and the 50-day moving average remains a level of chart resistance.

blue stock dec 10


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI